−0.004 SGD
−2.49 M SGD
1.31 M SGD
1.68 B
About BIOLIDICS
Sector
Industry
Headquarters
Singapore
Website
Founded
2009
ISIN
SGXE89830751
FIGI
BBG00MS99S28
Biolidics Ltd. is a medical technology company, which engages in the development of diagnostic solutions. It operates through the following segments: Cancer, Infectious Diseases, Laboratory Services, and Corporate. The Cancer segment includes identifying and assessing potential collaboration partners, technology, products and services, development, innovation and improvement, and the management of distributorship network and direct customers in the cancer field. The Corporate segment focuses on supporting the operations of the entire Group. The company was founded by Johnson Chen on July 19, 2009 and is headquartered in Singapore.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8YY is 0.028 SGD — it has decreased by −3.45% in the past 24 hours. Watch BIOLIDICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SGX exchange BIOLIDICS stocks are traded under the ticker 8YY.
8YY stock has risen by 3.70% compared to the previous week, the month change is a 115.38% rise, over the last year BIOLIDICS has showed a 100.00% increase.
8YY stock is 10.71% volatile and has beta coefficient of 0.25. Track BIOLIDICS stock price on the chart and check out the list of the most volatile stocks — is BIOLIDICS there?
Today BIOLIDICS has the market capitalization of 49.03 M, it has decreased by −25.00% over the last week.
Yes, you can track BIOLIDICS financials in yearly and quarterly reports right on TradingView.
8YY net income for the last quarter is −420.00 K SGD, while the quarter before that showed −688.00 K SGD of net income which accounts for 38.95% change. Track more BIOLIDICS financial stats to get the full picture.
No, 8YY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 15.00 employees. See our rating of the largest employees — is BIOLIDICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOLIDICS EBITDA is −2.68 M SGD, and current EBITDA margin is −173.69%. See more stats in BIOLIDICS financial statements.
Like other stocks, 8YY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOLIDICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOLIDICS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOLIDICS stock shows the buy signal. See more of BIOLIDICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.